Subcutaneous Phaeohyphomycosis in a Renal Transplant Patient by a Rare Fungus Medicopsis romeroi

Saudi J Kidney Dis Transpl. 2023 Nov 1;34(6):655-659. doi: 10.4103/sjkdt.sjkdt_218_23. Epub 2024 May 9.

Abstract

Medicopsis romeroi is a dematiaceous fungus that rarely causes subcutaneous phaeohyphomycosis. Here, we report a subcutaneous phaeohyphomycosis caused by a rare dematiaceous fungus, M. romeroi, in a 56-year-old male renal transplant patient. The patient was admitted for graft dysfunction and was found to have painless swelling over the anterior aspect of the right knee, which was aspirated twice within 40 days. Broad septate hyphae (determined by microscopy) and growth of phaeoid in a culture were observed in both the specimens. No sporulation was observed in the slide culture. Swelling recurred even after treatment with voriconazole, so the lesion was surgically excised. Genotypically, the isolate was identified as M. romeroi in both specimens. He was discharged on voriconazole. During a 6-month follow-up, no relapse was noticed. Phaeohyphomycosis caused by M. romeroi is rare, with only a few cases reported in India. Laboratory diagnosis of Medicopsis by conventional methods is challenging. Medicopsis species should be considered one of the etiological agents for subcutaneous phaeohyphomycosis. Molecular methods should be used for the identification of unusual pathogens.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents* / therapeutic use
  • Ascomycota / genetics
  • Ascomycota / isolation & purification
  • Humans
  • Immunocompromised Host
  • Kidney Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Phaeohyphomycosis* / diagnosis
  • Phaeohyphomycosis* / drug therapy
  • Phaeohyphomycosis* / microbiology
  • Treatment Outcome
  • Voriconazole* / therapeutic use

Substances

  • Antifungal Agents
  • Voriconazole